What is Blackbird Critical Metals Corp?
operates as biopharmaceutical company that develops transdermal delivery system for obesity and metabolic disorders.
BBCMF · Verdict
Limited reward · elevated risk
BBCMF's standout is volatility; cash flow and profitability weigh on the picture.
Based on 88% data coverage
BBCMF · Verdict
Top decile vs peers
Weak vs peers
0% return on equity
Below average
Current ratio 0.60
Earnings +325.0% CAGR
Model-based scoring. For information only — not financial advice.
operates as biopharmaceutical company that develops transdermal delivery system for obesity and metabolic disorders. The company was incorporated in 2024 and is based in Vancouver, Canada. The company is listed on the OTCQB in USA, operating in the Healthcare sector, with a market capitalisation of 9.64M.
The scoring profile indicates weak reward characteristics across most factors, including momentum and size. Risk indicators are elevated — volatility and macro sensitivity warrant consideration.
For informational purposes only. Not financial advice.